Factitious increases in serum testosterone concentrations related to phenylbutazone therapy.
We report 6 additional observations of a drug/hormone assay interaction between serum testosterone and phenylbutazone intake. This interaction had been described previously only once. We discuss its potential mechanisms, based upon our experimental findings, and its clinical implications.
DOI: 10.1111/j.1472-8206.2007.00564.x
Version: za2963e q8za1 q8zb0 q8zcb q8zd2 q8ze8 q8zf2 q8zg0